Current Venous Thromboembolism Management and Outcomes in JapanMashio Nakamura, Tetsuhito Kojima, Naoki Unno et al.|Circulation Journal|2014Cited by 129
Prediction Models for Two Year Overall Survival and Amputation Free Survival After Revascularisation for Chronic Limb Threatening IschaemiaTetsuro Miyata, Yasuhiro Yunoki, Hiraku Kumamaru et al.|European Journal of Vascular and Endovascular Surgery|2022Cited by 34
A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study)Yasuo Okumura, Masatoshi Koga, Tsutomu Yamazaki et al.|Circulation Journal|2020Cited by 23
Safety Profile and Effectiveness of Rivaroxaban for Patients With Venous Thromboembolism in Japan ― Results From Post-Marketing Surveillance (XASSENT) ―Ikuo Fukuda, Takanori Hayasaki, Atsushi Hirayama et al.|Circulation Journal|2023Cited by 3
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)Ikuo Fukuda, Takanori Hayasaki, Atsushi Hirayama et al.|TH Open|2021Cited by 2